Services

Dry Powder Formulation Development

MVIC supports you with experts in inhalation formulation development. Access support for dry powder inhaler formulation, device testing, and feasibility studies.

Tailored support for dry powder formulation development

Dry powder formulation development is a critical part of bringing effective and stable inhaled drug products to market. At MVIC, we specialise in developing dry powder formulations for pulmonary drug delivery. Our team supports you from early feasibility through to optimised powder inhalation systems, ensuring each formulation meets both performance expectations and regulatory requirements. Whether you are initiating a new development or improving an existing product, we offer a tailored and collaborative approach.

Our Services and Capabilities

MVIC provides end-to-end support within dry powder formulation development, with services grouped into four key areas. Each area is designed to ensure your dry powder product is well-characterised, stable, device-compatible, and ready for clinical or commercial development.

Formulation Design, Processing and Scale-up

We develop and scale up dry powder inhaler formulations with a strong focus on quality, device compatibility, and process control. Using specialised equipment and controlled environments, we design dry formulations for powder inhalation, including particle size reduction and advanced blending techniques. Typical formulations may include micronised lactose and ternary agents like magnesium stearate to optimise performance.

Device Compatibility and Inhaler Testing

We ensure optimal pairing between dry powder inhaler formulations and devices. Our services include in-vitro testing (emitted dose, fine particle fraction), capsule filling evaluation, and aerodynamic performance using cascade impaction — all essential for effective powder inhalation delivery.

Powder Characterisation and Stability

A deep understanding of solid-state properties is essential in dry powder inhaler formulation. We assess crystallinity, thermal behavior, particle morphology, and stability to ensure each dry formulation performs reliably under real-world conditions.

Project Management

We manage your dry formulation project from early feasibility to clinical readiness. Our team coordinates formulation, analytical, and device workstreams, ensuring seamless collaboration and regulatory-ready results throughout the powder inhalation development process.

FAQs

Here you’ll find answers to some of the most common questions we receive. Still wondering about something? Feel free to get in touch – we’re happy to tell you more!

Yes, we offer reformulation and troubleshooting support to improve performance or meet updated regulatory requirements.
We evaluate powder properties, device compatibility, and stability to ensure consistent dosing and optimal lung deposition.
Powder inhalation involves delivering drugs in dry powder form directly to the lungs using DPI devices. It offers convenience and effective local or systemic delivery.
It refers to the development of inhaled drug formulations designed for delivery to the lungs, with a focus on performance, stability, and compatibility with devices.